Fouad Nawaz - 14 Sep 2026 Form 4 Insider Report for EXOZYMES INC. (EXOZ)

Reporting relationship: Vice President- Finance
Issuer ticker: EXOZ
Reported as of: 14 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Sep 2026, 17:27:28 UTC
Prior SEC filing: 08 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Fouad Nawaz

Key filing fact

Fouad Nawaz filed Form 4 for EXOZYMES INC. (EXOZ) on 17 Sep 2026.

Key facts

This page summarizes Fouad Nawaz's Form 4 filing for EXOZYMES INC. (EXOZ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Sep 2026, 17:27.

Change

Previous filing in this sequence was filed on 08 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002030838 Primary reporting owner

Nawaz Fouad

Relationship: Vice President- Finance
Address: C/O 750 ROYAL OAKS DRIVE,, SUITE 106, MONROVIA
Signature: /s/ Fouad Nawaz
Signature date: 17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EXOZ holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 9,488
Date: 14 Sep 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXOZ transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +45,000
Change %
Price: $0.000000^*
Shares after: 45,000
Date: 14 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,000
Exercise price: $6.28
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests over a three (3) year period in twelve (12) equal quarterly installments of 3,750 shares at the end of each quarter of the calendar year, commencing with the first full calendar quarter following the date of grant. The first installment vests on 12/31/2026 and the final installment vests on 09/30/2029. The option expires on 09/14/2033.